Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes
Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes
Chlamydia trachomatis is the most common bacterial sexually transmitted infection worldwide and the leading cause of preventable blindness in developing countries. Tetracycline is commonly the drug of choice for treating C. trachomatis infections, but cases of antibiotic resistance in clinical isolates have previously been reported. Here, we used antibiotic resistance assays and whole-genome sequencing to interrogate the hypothesis that two clinical isolates (IU824 and IU888) have acquired mechanisms of antibiotic resistance. Immunofluorescence staining was used to identify C. trachomatis inclusions in cell cultures grown in the presence of tetracycline; however, only antibiotic-free control cultures yielded the strong fluorescence associated with the presence of chlamydial inclusions. Infectivity was lost upon passage of harvested cultures grown in the presence of tetracycline into antibiotic-free medium, so we conclude that these isolates were phenotypically sensitive to tetracycline. Comparisons of the genome and plasmid sequences for the two isolates with tetracycline-sensitive strains did not identify regions of low sequence identity that could accommodate horizontally acquired resistance genes, and the tetracycline binding region of the 16S rRNA gene was identical to that of the sensitive control strains. The porB gene of strain IU824, however, was found to contain a premature stop codon not previously identified, which is noteworthy but unlikely to be related to tetracycline resistance. In conclusion, we found no evidence of tetracycline resistance in the two strains investigated, and it seems most likely that the small, aberrant inclusions previously identified resulted from the high chlamydial load used in the original antibiotic resistance assays.
748-756
Seth-Smith, H.M.B.
507203f1-4326-4fb4-a940-4d1f4e48dc2d
Van Der Pol, B.
98836bef-9471-4d17-8645-7d75f50c58da
Harris, S.R.
0a2d5889-42f6-4764-84db-f60fbe8d8594
Thomson, N.R.
2ab67a93-2afc-4a98-b1e4-8d539b92b351
Cutcliffe, L.T.
8e4ac702-377b-4d73-9e6b-9409bb2e253c
O'Neill, C.E.
3de0c221-6578-4a1a-96bd-2a3fba2b6193
Clarke, I.N.
ff6c9324-3547-4039-bb2c-10c0b3327a8b
April 2013
Seth-Smith, H.M.B.
507203f1-4326-4fb4-a940-4d1f4e48dc2d
Van Der Pol, B.
98836bef-9471-4d17-8645-7d75f50c58da
Harris, S.R.
0a2d5889-42f6-4764-84db-f60fbe8d8594
Thomson, N.R.
2ab67a93-2afc-4a98-b1e4-8d539b92b351
Cutcliffe, L.T.
8e4ac702-377b-4d73-9e6b-9409bb2e253c
O'Neill, C.E.
3de0c221-6578-4a1a-96bd-2a3fba2b6193
Clarke, I.N.
ff6c9324-3547-4039-bb2c-10c0b3327a8b
Seth-Smith, H.M.B., Van Der Pol, B., Harris, S.R., Thomson, N.R., Cutcliffe, L.T., O'Neill, C.E. and Clarke, I.N.
(2013)
Chlamydia trachomatis clinical isolates identified as tetracycline resistant do not exhibit resistance in vitro: whole-genome sequencing reveals a mutation in porB but no evidence for tetracycline resistance genes.
Microbiology, 159 (4), .
(doi:10.1099/mic.0.065391-0).
(PMID:23378575)
Abstract
Chlamydia trachomatis is the most common bacterial sexually transmitted infection worldwide and the leading cause of preventable blindness in developing countries. Tetracycline is commonly the drug of choice for treating C. trachomatis infections, but cases of antibiotic resistance in clinical isolates have previously been reported. Here, we used antibiotic resistance assays and whole-genome sequencing to interrogate the hypothesis that two clinical isolates (IU824 and IU888) have acquired mechanisms of antibiotic resistance. Immunofluorescence staining was used to identify C. trachomatis inclusions in cell cultures grown in the presence of tetracycline; however, only antibiotic-free control cultures yielded the strong fluorescence associated with the presence of chlamydial inclusions. Infectivity was lost upon passage of harvested cultures grown in the presence of tetracycline into antibiotic-free medium, so we conclude that these isolates were phenotypically sensitive to tetracycline. Comparisons of the genome and plasmid sequences for the two isolates with tetracycline-sensitive strains did not identify regions of low sequence identity that could accommodate horizontally acquired resistance genes, and the tetracycline binding region of the 16S rRNA gene was identical to that of the sensitive control strains. The porB gene of strain IU824, however, was found to contain a premature stop codon not previously identified, which is noteworthy but unlikely to be related to tetracycline resistance. In conclusion, we found no evidence of tetracycline resistance in the two strains investigated, and it seems most likely that the small, aberrant inclusions previously identified resulted from the high chlamydial load used in the original antibiotic resistance assays.
This record has no associated files available for download.
More information
Published date: April 2013
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 350915
URI: http://eprints.soton.ac.uk/id/eprint/350915
PURE UUID: 5cf4bc3a-b2c9-492a-9fe9-98f664d7cdb0
Catalogue record
Date deposited: 10 Apr 2013 16:52
Last modified: 15 Mar 2024 02:33
Export record
Altmetrics
Contributors
Author:
H.M.B. Seth-Smith
Author:
B. Van Der Pol
Author:
S.R. Harris
Author:
N.R. Thomson
Author:
L.T. Cutcliffe
Author:
C.E. O'Neill
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics